Leland G. Richardson

[The Journal of Immunology @J_Immunol]

Congratulations to new Nobel Laureate and AAI Distinguished Fellow Shimon Sakaguchi, co-winner of the 2025 @NobelPrize in Physiology or Medicine for his foundational discoveries on regulatory T cells and peripheral immune tolerance! Published in The JI: https://t.co/FAcszhA6TH.

[Leland G. Richardson @LGKRichardson]

@SMaheenBatool1 @muhdalam Congratulations Maheen!!

[Leland G. Richardson @LGKRichardson]

@l_muzyka @TheNRMP @UWNeurosurgery @DellMedSchool @ladyspinedoc Congratulations Logan!!!!

[Leland G. Richardson @LGKRichardson]

Congratulations @rishabrama on this momentous day!! Proud of you and your accomplishments!

[Penn Neurosurgery @PennNSG]

We're thrilled to announce that @marceldagli, @MichelotMichel, and @rishabrama have matched into our #Neurosurgery Residency Program!

#Match2025 #MatchDay

[MIT Picower Institute @MIT_Picower]

A new technology developed at MIT enables scientists to label proteins across millions of individual cells in fully intact 3D tissues with unprecedented speed, uniformity, and versatility. https://t.co/oDsdgpYNmN #neuroscience @MITChemE @ScienceMIT @MIT_IMES @mitbrainandcog

[Leland G. Richardson @LGKRichardson]

Special thanks to @WTCNeuroscience , @egrewal1 and rest of our team at @MGHNeurosurg, @MGBneurosurgery

[Leland G. Richardson @LGKRichardson]

Incredible #SNO2024 meeting in the books! Truly honored for the opportunity to discuss our work and share the stage with such incredible scientists. Thank you @BryanDChoi for your mentorship and unwavering support all these years. Excited for next year!

[Bryan D. Choi MD PhD @BryanDChoi]

Congrats @LGKRichardson @MGHNeurosurg for his talk and on receiving the Molecular Pathology Award at #SNO2024 @NeuroOnc !

[Nature Cancer @NatureCancer]

🔉ARTICLE ONLINE @NatureCancer NOW!

'Evolving cell states and oncogenic drivers during the progression of IDH-mutant gliomas'
✏️By Bradley Bernstein @BradEBernstein and colleagues

📎https://t.co/Yu5KCUfy7e

[Nature Communications @NatureComms]

.@BalajLeonora @BobCarterMD @SmaheenBatool1 develop an RNA-based Droplet Digital PCR assay to detect key #IDH1 mutation in plasma biopsies from #glioma patients with high sensitivity
#CancerResearch @NatResCancer https://t.co/lOi2MAozRk

[Michelle Monje 🟦 @michelle_monje]

#CARTcells for #DIPG #DMG clinical trial (1st arm) results are out today. Full Tweetorial coming, but first want to share the story of a patient whose #DIPG has disappeared for over 3 years. It is a milestone and moment of hope on a journey filled with so much grief.
“There’s a lot of loss that led to this research,” Drew’s dad said. “I hope those families know that this success is because of them.”
https://t.co/rNnHkL6pQR

[Eric Topol @EricTopol]

A huge day for spatial omics of cancer, tracing the precise origin and evolution of 20 types of cancer, many in 3D, in ~2,000 individuals, with 12 publications @Nature @NatureCancer @NatureMedicine @naturemethods @CommsBio
Collection https://t.co/w2KFK4WP6V

[Science Magazine @ScienceMagazine]

Two recent phase 1 trials hint that bivalent #CARTcell therapies could overcome persistent barriers in the treatment of #glioblastoma, according to a new @ScienceTM Focus. https://t.co/7XATpleHcj

[Nature Biotechnology @NatureBiotech]

A CAR enhancer increases the activity and persistence of CAR T cells https://t.co/Zb9sFG1G4P

[Bryan Johnson @bryan_johnson]

Researchers Marcela Maus and Bryan Choi at Mass General achieved a breakthrough in glioblastoma treatment using genetically modified T cells, showing dramatic tumor regression. This immunotherapy could revolutionize cancer treatment.

[Bryan D. Choi MD PhD @BryanDChoi]

Gliomas with IDH mutations have fewer suppressive myeloid cells, and may set the stage for cell therapy w/ #CARTcells. Awesome work @egrewal1 @LGKRichardson published yesterday in @CCR_AACR
@MGHNeurosurg @MGBneurosurgery

https://t.co/t1vBKvhpOU

[Rishab Ramapriyan, MD @rishabrama]

Excited to share our new review on altered cancer metabolism and implications for next-generation CAR T-cell therapies-- written with @VivaVykunta @GustVandeca @LGKRichardson @WTCNeuroscience
@BryanDChoi @MGHNeurosurg Full Paper: https://t.co/sNV5uduICx

[Cell @CellCellPress]

Now online! Circadian tumor infiltration and function of CD8+ T cells dictate immunotherapy efficacy https://t.co/cS6aLVjd4O

[Science Immunology @SciImmunology]

A natural killer ligand on activated #Tcells could be a new checkpoint to target in multiple #immune diseases and #cancer, according to new research. @broadinstitute @Platten_lab @DKFZ

📄: https://t.co/zqyrdmR9PJ

[Bryan D. Choi MD PhD @BryanDChoi]

Check out this quick read from @NeuroOnc on CART studies for #glioblastoma, all published within a few days of each other by our group and colleagues @PennMedicine and @cityofhope
https://t.co/jkwVeC527Y

[Brown Neurosurgery @BrownNSGY]

Dr. Christine Lee @CKLeeMD will serve as the director of our Endoscopic Skull Base Surgery Program and co-director of skull base surgery at the Norman Prince Neurosciences Institute of Lifespan. Learn more in this interview with PBN https://t.co/WHdTB7JNIf